Enrichment of Phosphorylated MHC Peptides with Immobilized Metal Affinity Chromatography and Titanium Dioxide

Rui Chen1, Jianjun Li2

  • 1Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.

Insights

This study introduces a novel method for enriching phosphopeptides from the immunopeptidome. This technique enhances the identification of potential neoantigens for cancer immunotherapy by improving mass spectrometry detection.

Area of Science:

  • Biochemistry
  • Immunology
  • Cancer Research

Background:

  • Phosphorylation is a key posttranslational modification implicated in cancer signaling pathways.
  • Aberrantly phosphorylated proteins presented by major histocompatibility complex (MHC) are promising targets for neoantigen-based immunotherapy.
  • Identifying these phosphopeptides is challenging as they cannot be predicted from DNA sequences.

Purpose of the Study:

  • To develop an effective method for enriching phosphopeptides from the immunopeptidome for mass spectrometry (MS) detection.
  • To improve the identification of specific phosphopeptides for cancer immunotherapy.

Main Methods:

  • Combined use of immobilized metal affinity chromatography (IMAC) and titanium dioxide (TiO2) nanoparticles.
  • Enrichment of phosphopeptides from the complex immunopeptidome.

Main Results:

  • Successfully enriched phosphopeptides from the immunopeptidome.
  • The described method facilitates the direct detection of phosphopeptides using MS.

Conclusions:

  • The combined IMAC and TiO2 nanoparticle approach is effective for phosphopeptide enrichment.
  • This method aids in the identification of potential neoantigens for targeted cancer immunotherapy.